After the hype, a thoughtful, responsible approach to improving sexual function. The viagra revolution is here, and while the drug truly can help many of the millions of Americans who seek it, it can create as many problems as it can cure. Here is the first book to help readers-men and women together-understand some of the common root causes of sexual dysfunction and determine whether the quick fix of Viagra will help them, or possibly make their situation worse. Dr. Melchiode, who participated in some of the early clinical trials of Viagra, gives the reader a tour of the sexual psyche, pointing out the obstacles and pitfalls posed by treatment, whether with drugs or through other means. Most important, he makes the critical point that men must involve their partners in the treatment, and offers sage advice on how to do so in a positive and loving manner. He also discusses such thorny issues as the role of the physician, the relationship with one's insurer or HMO, and the potential impact of Viagra-both good and bad-on male-female relations, and society in general.

From Aspirin to Viagra, insulin to penicillin, and vaccines to vitamin supplements, drugs have become part of our everyday lives. This staggering global industry wasn’t born overnight; advancements in pharmaceutical science have been happening for a long while, over the course of decades and even centuries. This book tells the history of ten prominent substances and how they came to be common household names. It shows how the creation of such influential drugs often began with the right person at the exactly right—or wrong!— time. The chapters tell the stories of geniuses and charlatans; scholars and amateurs; advances won through hard work or pure luck; and ultimately, the handful of resounding successes that revolutionized a global industry. Beyond the pioneers of the most famous drugs in our culture, the book analyzes how our perspective on medical treatment has shifted over the decades. Modern standards for testing and administering substances have created a new set of advantages, setbacks, and stigmas, all of which are discussed herein.

Healthy alternatives to the wonder drug.

Blue Ocean Strategy, the #1 global bestseller, forever changed how the world thinks about strategy. Now W. Chan Kim and Renée Mauborgne offer up a bold, new idea that will transform how we all think about innovation and growth. Disruption dominates innovation theory and practice. But disruption, for all its power, is destructive—displacing jobs, companies, and even entire industries. Are we missing an alternative approach to innovation and growth? With three decades of research, the #1 global bestselling authors of Blue Ocean Strategy, W. Chan Kim and Renée Mauborgne, reveal another way to innovate and grow. Just as Blue Ocean Strategy redefined the essence of strategy as creating not competing, Beyond Disruption redefines and expands the existing view of innovation by introducing a new approach, nondisruptive creation, that is free from the destructive displacement that happens when innovators set out to disrupt. Kim and Mauborgne reveal the distinct advantages of nondisruptive creation to business and society, showing how this new approach to innovation allows companies to grow while also being a force for good. With examples that reach across all sectors of the economy and a practical framework for guiding innovation efforts, this book shows: Why nondisruptive creation matters to all of us and why it is likely to become even more important in the future How it complements disruption and how you can identify and execute on nondisruptive opportunities How companies can more thoughtfully pursue their growth and innovation strategies in a way that better balances business and society A practical guide for driving innovation and growth, the rich research behind the book, coupled with its frame-breaking message, make it the must-read book for the next generation of innovators.

Never before in the history of medicine has mankind faced such hope and peril as those of us poised to embrace the radical medical technologies of today. Eve Herold's Beyond Human examines the medical technologies taking shape at the nexus of computing, microelectronics, engineering, nanotechnology, cellular and gene therapies, and robotics. These technologies will dramatically transform our lives and allow us to live for hundreds of years. Yet, with these blessings come complicated practical and ethical issues, some of which we can predict, but many we cannot. Beyond Human taps the minds of doctors, scientists, and engineers engaged in developing a host of new technologies while telling the stories of some of the patients courageously testing the radical new treatments about to come into the market. Beyond Human asks the difficult questions of the scientists and bioethicists who seek to ensure that as our bodies and brains become ever more artificial, we hold onto our humanity. In this new world, will everyone have access to technological miracles, or will we end up living in a world of radical disparities? How will society accommodate life spans that extend into hundreds of years? Will we and our descendants be able to bring about the dream of a future liberated by technology, or will we end up merely serving the machines and devices that keep us healthy, smart, young, and alive?

All businesses operate under a set of rules – laws and regulations – that occasionally require updating. Improving these 'rules of the competitive game' can, sometimes, be vital for a business or industry to survive. Strategy Beyond Markets explains how the rules of the competitive game are changed, and what role the business sector can play in this change. Through the analysis of case studies, a new discipline called Strategy Beyond Markets is presented. It studies how business regulations–taxes, subsidies, compliance rules, production and marketability standards, licensing requirements–come about, and why they take certain forms. This discipline helps businesses operate effectively in the politico-regulatory arenas where the rules of the competitive game are made. Strategy Beyond Markets complements, but is fundamentally different from, the traditional discipline of Competitive Strategy.

Since the FDA approved Viagra in March 1998, the «little blue pill» has been prescribed to over twenty million men. The Viagra Ad Venture: Masculinity, Media, and the Performance of Sexual Health chronicles the story of Viagra as reported in our nation's news outlets and promoted by Pfizer Pharmaceutical's marketing materials. In this critical discourse analysis, author Jay Baglia uses feminist and performance theory to uncover the meaning of Viagra and its relationship to performances of masculinity. At stake are the ways in which we construct normalcy, particularly as it relates to health, sexuality, gender, and the body. This book fits well in a variety of classes including gender studies, media studies, research methods, feminist theory, human sexuality, and health communication.

This book gives an outline which can enlighten, inspire, as well as provoke thought for readers who may express an interest in related ideas. This is a story about how and why the lack of love in the black community has almost destroyed this community. The volumes touch upon certain political and social conditions which may occur in a sometimes uncertain modern society. The author shows an understanding of history that considers how certain aspects of life may have unfolded over time. This book explains the need to explain the difference between entertainment and production as a career choice for children. He cites the importance of education with a relevant economic component... This really is a story that is yet to be told!

Saturday, December 14, 2013. The case ended up taking seven hours. Her incision stretched from pubic bone to sternum. Although saturated with narcotic, she awakened writhing in pain. Any more pain meds . . . and she’d quit breathing. With help to carefully turn and position her onto her side, I then slipped in an epidural catheter. I put it up high, to be sure the band of numbness would cover the length of her incision. Within minutes after the first dose, she morphed into an entirely different person, chatting with us. Need for IV narcs, gone. She was able to take deep breaths and cough without pain. How could I have lived with myself had I not taken this extra step? It likely helped shorten her hospital stay and reduce the cost. Curses to any payer claiming epidurals for post-op pain are not necessary. Damn any CEO taking credit for the savings while putting a portion into his own pocket.

Beyond Safety argues that concerns about the ethical impossibility of individual safety in the face of risks with increasingly obvious global consequences alters representations of neoliberal contemporary life. As the climate crises in the Caribbean and Australia, ongoing European refugee and American border crises, and, most recently, anxieties about Coronavirus illustrate, contemporary life is characterized by global connections that produce and reflect precarious outcomes and dangers. The ability to ignore risk or shift it to others underscores the fact that it is mitigable for particular segments of society while inescapable for others. Emily Johansen investigates depictions of global danger and safety in contemporary transnational fictional and popular texts-those characterized by a narrative or representational emphasis on border crossing and global interdependences. She demonstrates how these texts use risk to question and re-imagine the norms and practices of contemporary global citizenship. Beyond Safety thus brings together three of the central keywords of contemporary literary criticism of the last ten years (cosmopolitanism, precarity, neoliberalism) and shows how their intersection allows for a fuller conception of contemporary life and imagines a new global future.